CD8+ TILs and Breast Cancer: Identifying New Opportunities for Immunotherapeutic Intervention
CD8+ TILs and Breast Cancer: Identifying New Opportunities for Immunotherapeutic Intervention
腾讯云视频点播
阿里云视频点播
https://outin-9a16319b20f811f1844a00163e32a995.oss-cn-shanghai.aliyuncs.com/sv/29e0c28f-19cf5ed0b29/29e0c28f-19cf5ed0b29.mp4?Expires=1773905679&OSSAccessKeyId=LTAI8bKSZ6dKjf44&Signature=wxq6XSCCexOdqV3o9LVd%2BvPaFP4%3D
In this webinar, Dr. Egelston discusses recent efforts to isolate and characterize phenotypically and functionally exhausted CD8+ TILs from a subset of breast tumors.
发布日期: 08/30/2019

EasySep™小鼠TIL(CD45)正选试剂盒



沪公网安备31010102008431号